1.
Centonze D, Iannazzo S, Santoni L, et al. Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis. Farmeconomia. Health Economics and Therapeutic Pathways. 2018;19(1). https://doi.org/10.7175/fe.v19i1.1385